The Food and Drug Administration awarded priority review vouchers to three companies developing psychedelic-based treatments for mental health conditions — two studying psilocybin for hard-to-treat depression and one studying methylone, an MDMA-related drug, for PTSD.
Bugle Call – America First to Make America Great Again supporting Civil Liberties, Election Integrity, Bill of Rights, and Religious Freedoms that will MAGA.
